RUBICON FDA Approval March 23, 2024, 22:06 UTC 42 0 comments FDA approve BUPRENORPHINE HYDROCHLORIDE Comment Full text
TARO FDA Approval March 23, 2024, 22:06 UTC 33 0 comments FDA approve MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE Comment Full text
TEVA PHARMS USA FDA Approval March 23, 2024, 22:06 UTC 37 0 comments FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE Comment Full text
ABBVIE ENDOCRINE INC FDA Approval March 23, 2024, 22:06 UTC 46 0 comments FDA approve LEUPROLIDE ACETATE Comment Full text
AVEVA FDA Approval March 23, 2024, 22:06 UTC 36 0 comments FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE Comment Full text
IMMUNOGEN INC FDA Approval March 23, 2024, 22:06 UTC 48 0 comments FDA approve MIRVETUXIMAB SORAVTANSINE-GYNX Comment Full text
JANSSEN BIOTECH FDA Approval March 23, 2024, 22:06 UTC 50 0 comments FDA approve USTEKINUMAB Comment Full text
ACTAVIS ELIZABETH FDA Approval March 23, 2024, 22:06 UTC 42 0 comments FDA approve BUPRENORPHINE HYDROCHLORIDE Comment Full text
QILU FDA Approval March 23, 2024, 22:06 UTC 49 0 comments FDA approve AMIKACIN SULFATE Comment Full text
CHARTWELL MOLECULAR FDA Approval March 23, 2024, 22:06 UTC 26 0 comments FDA approve ESCITALOPRAM OXALATE Comment Full text